NO156408C - AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater. - Google Patents

AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.

Info

Publication number
NO156408C
NO156408C NO821997A NO821997A NO156408C NO 156408 C NO156408 C NO 156408C NO 821997 A NO821997 A NO 821997A NO 821997 A NO821997 A NO 821997A NO 156408 C NO156408 C NO 156408C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
proline derivatives
analogical procedure
analogical
Prior art date
Application number
NO821997A
Other languages
English (en)
Norwegian (no)
Other versions
NO821997L (no
NO156408B (no
Inventor
Sadao Tanaka
Kiyonori Kuromaru
Yasuo Fujimura
Isao Matsunaga
Tomoyasu Iwaoka
Noriko Obatake
Junichiro Aono
Yoshikazu Hinohara
Hideki Nakono
Masafumi Fukushima
Hiroyuki Nabata
Kazushige Sakai
Shun-Ichi Hata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56094002A external-priority patent/JPS57209270A/ja
Priority claimed from JP56137823A external-priority patent/JPS5839661A/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO821997L publication Critical patent/NO821997L/no
Publication of NO156408B publication Critical patent/NO156408B/no
Publication of NO156408C publication Critical patent/NO156408C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO821997A 1981-06-19 1982-06-16 AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater. NO156408C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative
JP56137823A JPS5839661A (ja) 1981-09-03 1981-09-03 プロリン誘導体の製法

Publications (3)

Publication Number Publication Date
NO821997L NO821997L (no) 1982-12-20
NO156408B NO156408B (no) 1987-06-09
NO156408C true NO156408C (no) 1987-09-16

Family

ID=26435270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821997A NO156408C (no) 1981-06-19 1982-06-16 AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.

Country Status (19)

Country Link
KR (1) KR890000769B1 (fr)
AT (1) AT377496B (fr)
CA (1) CA1235120A (fr)
CH (1) CH651825A5 (fr)
DE (1) DE3222779A1 (fr)
DK (1) DK156054C (fr)
ES (2) ES8307216A1 (fr)
FI (1) FI75804C (fr)
FR (1) FR2508040B1 (fr)
GB (1) GB2102412B (fr)
HU (1) HU188177B (fr)
IL (1) IL65954A (fr)
IT (1) IT1157053B (fr)
MX (2) MX155724A (fr)
NL (1) NL193282C (fr)
NO (1) NO156408C (fr)
PT (1) PT75076B (fr)
SE (1) SE453595B (fr)
SU (1) SU1316556A3 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
KR870007114A (ko) * 1986-01-21 1987-08-14 우에노 기미오 티올 에스테르 유도체의 안정된 고형제
ZA896851B (en) 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
EP0634175B1 (fr) * 1993-07-15 2001-01-10 F. Hoffmann-La Roche Ag Combinaison pharmaceutique contenant un inhibiteur du système rénin-angiotensin et un antagoniste d'endothéline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Also Published As

Publication number Publication date
ATA558581A (de) 1984-08-15
DE3222779A1 (de) 1983-01-27
MX155724A (es) 1988-04-20
GB2102412A (en) 1983-02-02
PT75076B (en) 1984-05-09
CA1235120A (fr) 1988-04-12
ES513277A0 (es) 1983-07-01
FI822171A0 (fi) 1982-06-16
NL193282C (nl) 1999-05-06
DK156054C (da) 1989-11-06
ES520582A0 (es) 1984-04-01
DE3222779C2 (fr) 1991-01-03
SE8203814L (sv) 1982-12-20
NO821997L (no) 1982-12-20
MX171888B (es) 1993-11-23
CH651825A5 (de) 1985-10-15
IT1157053B (it) 1987-02-11
ES8403868A1 (es) 1984-04-01
GB2102412B (en) 1985-01-09
NO156408B (no) 1987-06-09
IL65954A (en) 1986-03-31
FR2508040B1 (fr) 1986-07-04
DK156054B (da) 1989-06-19
FI822171L (fi) 1982-12-20
IL65954A0 (en) 1982-09-30
FR2508040A1 (fr) 1982-12-24
SE453595B (sv) 1988-02-15
ES8307216A1 (es) 1983-07-01
PT75076A (en) 1982-07-01
FI75804B (fi) 1988-04-29
HU188177B (en) 1986-03-28
DK273082A (da) 1982-12-20
KR840000488A (ko) 1984-02-22
SU1316556A3 (ru) 1987-06-07
IT8267772A0 (it) 1982-06-16
NL193282B (nl) 1999-01-04
NL8202472A (nl) 1983-01-17
AT377496B (de) 1985-03-25
FI75804C (fi) 1988-08-08
KR890000769B1 (ko) 1989-04-05

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO872946L (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO157296C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(4-indolyl-piperidino-alkyl)-benzimidazolon-derivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO159929C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-substituerte 2-pyridylindoler.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO156408C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000